Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανάπτυξη αυτογαλακτωματοποιούμενων νανοφορέων χορηγούμενων από το στόμα για τη θεραπεία της Λεϊσμανίασης

Abstract

dc:description

The aim of this Doctoral Thesis is the methodology of investigating various types and proportions of oils, surfactants and co-solvents in the development of self-emulsifying drug delivery systems (SNEDDS), which are intended for the oral administration of active pharmaceutical ingredients. In addition, the possibility of incorporating multifunctional polymers and ionic liquids into these systems as alternative excipients which provide several advantages was investigated and their therapeutic efficacy in vitro, ex vivo and in vivo was evaluated. In particular, the first study aimed to investigate various combinations of the concentration of the excipients for the manufacture of preconcentrates of self-emulsifying drug delivery systems and their evaluation at various dilution ratios in different aqueous media. The most suitable formulation was chosen to carry out the incorporation of different concentrations of permeation enhancer and the Amphotericin B. Trimethyl-chitosan was used for this purpose, due to its improved absorption through paracellular transport through the tight synapses of cells in the small intestine. In addition, cellular studies were carried out in order to investigate the penetration of the active pharmaceutical ingredient and the cell viability after the application of the produced formulations. The second study focused on investigating the interaction of ionic liquids for the preparation of preconcentrates of self-emulsifying delivery systems of Amphotericin B, in order to enhance the aqueous solubility and permeability of the drug. Three different types of imidazole ionic liquids, namely 1-butyl-3-methylimidazole hexafluorophosphate (BMIMPF6), 1-butyl-3-methylimidazole tetrafluoroborate (BMIMBF4), and 1-hexyl-3-methylimidazole chloride (HMIMCl), which are found in liquid form at ambient temperature, were integrated into the already evaluated system of the previous study and evaluated in vitro in Caco-2 cells in terms of cell permeability and viability. The next stage of the study was a combination of the two previous studies and evaluated trimethyl-chitosan (TMC) and 1-hexyl-3-methylimidazolium chloride (HMIMCl) as enhancers of the absorption of Amphotericin B by the developed self-emulsifying systems. The static digestion model (in vitro) and the non-inverted intestinal gut sac model (ex vivo) were used to simulate the physiological process of drug absorption to predict the in vivo behavior. The in vivo evaluation of the therapeutic efficacy of the self-emulsifying systems was performed after oral administration to rats, in conjunction with the intravenous administration of a commercial formulation of Amphotericin B.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kontogiannidou, Eleni
  • Κοντογιαννίδου, Ελένη

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52433

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kontogiannidou, Eleni; Κοντογιαννίδου, Ελένη. Ανάπτυξη αυτογαλακτωματοποιούμενων νανοφορέων χορηγούμενων από το στόμα για τη θεραπεία της Λεϊσμανίασης. Aristotle University Of Thessaloniki (AUTH), 2022. http://hdl.handle.net/10442/hedi/52433